Skip to content
Open access · CC0 via OpenAlex

Senolytics and cell senescence: historical and evolutionary perspectives

Caleb E. Finch

Evolution Medicine and Public Health · 2024 · ▲ 5 citations

Abstract

Senolytics(definition) are a new class of anti-aging drugs developed to selectively kill 'senescent' cells that are considered harmful in normal aging. More than 20 drug trials are ongoing with diverse 'senolytic cocktails'. This commentary on recent reviews of senolytics gives a historical context of mammalian cell senescence(definition) that enabled these new drugs. While cell senescence is considered harmful to aging tissues, many studies show its essential role in some regenerative and developmental processes for which senolytic drugs may interfere. Longer-term studies of side effects are needed before senolytics are considered for general clinical practice. The wide occurrence of cell senescence in eukaryotes, yeast to fish to humans, and suggests an ancient eukaryotic process that evolved multiple phenotypes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/emph/eoae007
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Finch, C.E. (2024). Senolytics and cell senescence: historical and evolutionary perspectives. <em>Evolution Medicine and Public Health</em>. https://doi.org/10.1093/emph/eoae007
Vancouver
Finch CE. Senolytics and cell senescence: historical and evolutionary perspectives. Evolution Medicine and Public Health. 2024. doi:10.1093/emph/eoae007.
BibTeX
@article{caleb2024Senoly, title = {Senolytics and cell senescence: historical and evolutionary perspectives}, author = {Caleb E. Finch}, journal = {Evolution Medicine and Public Health}, year = {2024}, doi = {10.1093/emph/eoae007}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings